8-K current report · filed Aug 10, 2026

Ceribell, Inc. (CBLL) 8-K Current Report: August 10, 2026

Item EX-99.1Item 2.02CBLL overview

Short answer

Ceribell, Inc. (CBLL) filed an 8-K current report with the SEC on August 10, 2026 reporting Item EX-99.1 (Exhibit EX-99.1), Item 2.02 (Results of Operations and Financial Condition). Ceribell announced financial results for the quarter ended June 30, 2026.

Ceribell, Inc. 8-K event analysis

AI summary of each reported item and its exhibits

Item 2.02 · Results of Operations and Financial Condition

  • Ceribell announced financial results for the quarter ended June 30, 2026
  • Full results and management commentary are contained in Exhibit 99.1, dated August 10, 2026

Item EX-99.1 · Exhibit EX-99.1

  • Q2 revenue $28.1M, up 33%; product revenue $21.2M and subscription revenue $6.9M signal broad adoption
  • Gross margin reached 92% versus 88%, supported by Vietnam manufacturing and one-time tariff refunds
  • Net loss widened to $19.3M, or $0.51 per share, as operating expenses increased 37% to $45.9M
  • Cash, equivalents, and securities totaled $129.3M; new credit facility adds up to $60M committed capital
  • 2026 revenue guidance raised to $114M-$117M, while FDA clearances and October 1, 2026 NTAP eligibility support product expansion

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other Ceribell, Inc. 8-K filings

Get the next CBLL 8-K as it lands

Follow CBLL for push alerts, or ask the research agent what this filing means.